With the rise of telehealth weight loss services for adults (Hims, Ro, Found, Calibrate), some parents wonder: "Can my teen just use one of those?" The short answer is no, and the reasons go far beyond age restrictions.
Adolescent bodies are fundamentally different from adult bodies. They're still growing, developing, and maturing. A treatment program designed for a 40-year-old with metabolic syndrome is not appropriate for a 14-year-old who's still gaining height, building bone density, and navigating puberty.
Key differences at a glance
Why growth monitoring changes everything
The single biggest difference: adolescents are still growing. This means:
Adult programs don't measure height. They don't track pubertal staging. They don't adjust dosing for growth spurts. These aren't optional extras for adolescents; they're essential safety measures.
Wondering if this applies to your child? The 2-minute eligibility check tells you if Thryvwell could be a fit. No commitment, no payment info.
Dosing and the clinical evidence behind pediatric protocols
Pediatric GLP-1 treatment isn't adult treatment with a smaller dose, it follows its own evidence base. The landmark STEP TEENS trial (NEJM, 2022) enrolled adolescents ages 12–17 and demonstrated an average 16.1% BMI reduction over 68 weeks on semaglutide, alongside improvements in cardiometabolic risk factors, results that led to FDA approval for ages 12+.
Where pediatric dosing diverges from adult protocols:
What about young adults (18–26)?
Turning 18 doesn't make adult-oriented programs the right fit. Peak bone mass isn't reached until roughly age 25–30, hormonal patterns continue maturing through the early twenties, and the life context of a college student or early-career adult differs sharply from the 40+ patients most platforms are built around.
Young adults 18–26 also face a practical gap: they've aged out of pediatric practices but are often dismissed or generically treated by adult platforms. A program designed for this age range, with age-matched clinical protocols, communication style, and cost navigation (including staying on family insurance until 26), closes that gap. That's why Thryvwell's care for college students and young adults 18–26 uses developmental staging rather than a hard pediatric/adult split.
Cost pathways also differ by age: dependents under 26 can typically use family insurance for coverage and prior authorization. Our insurance and coverage guide covers coverage, prior authorization, and savings cards in detail.
The psychological dimension
Adolescence is a period of identity formation. A teen's relationship with their body, food, and self-image is fundamentally different from an adult's, and far more vulnerable.
Adult weight loss programs often use language and frameworks that can be harmful for developing minds:
Adult framing (harmful for teens)
- • "Before and after" transformation focus
- • Calorie counting and restriction language
- • Weight as the primary success metric
- • Individual responsibility framing
- • Appearance-based motivation
Pediatric framing (appropriate)
- • Health and energy as goals
- • Nourishment and adequacy language
- • Multiple health markers tracked
- • Family system approach
- • Function-based motivation (activities, confidence)
Pediatric programs train providers in adolescent-specific communication that avoids triggering disordered eating patterns or reinforcing weight stigma.
What to look for in a pediatric program
If you're evaluating treatment options for your adolescent, here's what distinguishes a genuine pediatric program from an adult program that accepts teens:
Common questions
Can my teen use an adult telehealth weight loss program like Ro or Hims?
No. Adult telehealth platforms are restricted to patients 18 and older, and their protocols are not designed for growing bodies. Adolescents 12–17 need pediatric-specific care with growth monitoring, conservative dose titration, and family involvement.
Is the GLP-1 medication itself different for teens and adults?
The medications are the same molecules, semaglutide (Wegovy) and liraglutide (Saxenda) are FDA-approved for ages 12+. What differs is everything around the prescription: titration speed, monitoring cadence, growth and pubertal tracking, and nutrition targets calibrated for development.
At what age should someone switch from pediatric to adult weight care?
There is no single cutoff. Many 18–26 year olds still benefit from a young-adult-focused program because their bone mass, hormonal patterns, and life circumstances differ from middle-aged patients. Thryvwell treats ages 12–26 with protocols staged by developmental phase.
Do teens lose as much weight as adults on GLP-1 medication?
In the STEP TEENS trial, adolescents on semaglutide achieved an average 16.1% BMI reduction over 68 weeks, comparable to or better than adult trial outcomes. Importantly, pediatric success is measured by healthy BMI trajectory alongside normal growth, not weight loss alone.
Sources
- AAP. Clinical Practice Guideline for Obesity Treatment: Pediatric-Specific Recommendations (2023)
- Weghuber, D. et al. "Once-Weekly Semaglutide in Adolescents with Obesity (STEP TEENS)." NEJM (2022)
- Cardel, M.I. et al. "Adolescent Obesity: Unique Considerations for Treatment." Obesity Reviews (2022)
- Pont, S.J. et al. "Stigma Experienced by Children and Adolescents With Obesity." Pediatrics (2017)
Built specifically for adolescents
Thryvwell is designed from the ground up for developing bodies and minds, not adapted from an adult program
The information on this page is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment.
